Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer
[This corrects the article DOI: 10.3389/fonc.2026.1818655.].
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
[This corrects the article DOI: 10.3389/fonc.2026.1818655.].
CD200 and its receptor CD200R form a myeloid-centered immune checkpoint that normally restrains myeloid activation and limits tissue damage, but many solid tumors co-opt this pathway to suppress antitumor immunity. CD200–CD200R signaling is highly context-dependent, varying even among models of the same cancer type. In...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.